Search results for "Edema"

showing 10 items of 625 documents

Drug-induced and iatrogenic infiltrative lung disease.

2004

At present more than 350 drugs are known to cause injury of the lung parenchyma,upper and lower airways, pulmonary circulation, pleura, mediastinum, lymph nodes,and neuromuscular system. Infiltrative lung disease (ILD) is the most common pattern of drug-induced injury. This article, which is clinically oriented rather than drug oriented, reviews the patterns of ILD produced by therapeutic drugs and radiation therapy.

Pulmonary and Respiratory MedicineDrugLung Diseasesmedicine.medical_specialtyDrug-Related Side Effects and Adverse Reactionsmedia_common.quotation_subjectIatrogenic DiseaseMEDLINEAmiodaronePulmonary EdemaSarcoidosis PulmonaryIatrogenic diseaseMedicineHumansIntensive care medicinemedia_commonbusiness.industryPneumoniamedicine.diseaseBreast radiationDermatologyPulmonary AlveoliMethotrexateLung diseaseSarcoidosisbusinessAnti-Arrhythmia AgentsClinics in chest medicine
researchProduct

Interstitial lung disease induced by drugs and radiation.

2004

An ever-increasing number of drugs can reproduce variegated patterns of naturally occurring interstitial lung disease (ILD), including most forms of interstitial pneumonias, alveolar involvement and, rarely, vasculitis. Drugs in one therapeutic class may collectively produce the same pattern of involvement. A few drugs can produce more than one pattern of ILD. The diagnosis of drug-induced ILD (DI-ILD) essentially rests on the temporal association between exposure to the drug and the development of pulmonary infiltrates. The histopathological features of DI-ILD are generally consistent, rather than suggestive or specific to the drug etiology. Thus, the diagnosis of DI-ILD is mainly made by …

Pulmonary and Respiratory MedicineDrugmedicine.medical_specialtyPathologymedia_common.quotation_subjectPulmonary FibrosisAmiodaronePulmonary EdemaMedicineHumansInterstitial pneumoniaPulmonary EosinophiliaDechallengeBronchiolitis ObliteransLungmedia_commonRadiotherapybusiness.industryRespiratory diseaseInterstitial lung diseasePneumoniarespiratory systemmedicine.diseaseDermatologyrespiratory tract diseasesPulmonary AlveoliRadiographyMethotrexateCorticosteroid therapyChronic DiseaseEtiologybusinessVasculitisLung Diseases InterstitialRespiration; international review of thoracic diseases
researchProduct

Haemoptysis in adults: a 5-year study using the French nationwide hospital administrative database.

2015

Haemoptysis is a serious symptom with various aetiologies. Our aim was to define the aetiologies, outcomes and associations with lung cancer in the entire population of a high-income country.This retrospective multicentre study was based on the French nationwide hospital medical information database collected over 5 years (2008–2012). We analysed haemoptysis incidence, aetiologies, geographical and seasonal distribution and mortality. We studied recurrence, association with lung cancer and mortality in a 3-year follow-up analysis.Each year, ∼15 000 adult patients (mean age 62 years, male/female ratio 2/1) were admitted for haemoptysis or had haemoptysis as a complication of their hospital s…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyPediatricsHemoptysisLung NeoplasmsDatabases FactualPulmonary EdemaRecurrenceEpidemiologyMedicineHumansHospital MortalityLung cancerAgedRetrospective StudiesAged 80 and overBronchiectasisbusiness.industryMortality rateIncidence (epidemiology)Retrospective cohort studyLength of StayMiddle Agedmedicine.diseaseEmbolization TherapeuticPulmonary embolismBronchiectasisFemaleFrancebusinessComplicationFollow-Up StudiesThe European respiratory journal
researchProduct

Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioede…

2022

Background Monitoring the effects of treatment on disease activity, impact, and control in patients with chronic spontaneous urticaria (CSU) is essential. We do not have enough information on how these features of CSU and its response to treatment are linked. Also, there is no information on how recurrent angioedema or coexisting chronic inducible urticaria (CIndU) affect their relation. The aim of this study was to analyse the link between disease activity, impact, and control in CSU patients and possible effects of recurrent angioedema and comorbid CIndU. Methods To perform these analyses, we validated the Polish version of the Urticaria Control Test (UCT) in 106 chronic urticaria patient…

Pulmonary and Respiratory MedicineUrticariaImmunologyValidationControlImmunology and AllergyUCTAngioedemaThe World Allergy Organization journal
researchProduct

Urticaria and bacterial infections

2014

The association between urticaria and infectious diseases has been discussed for >100 years. However, a causal relationship with underlying or precipitating infection is difficult to establish. The purpose of this work was to perform a systematic analysis of the published cases of urticaria associated with bacterial infections. We give an umbrella breakdown of up-to-date systematic reviews and other important publications on the complex association of urticaria and bacterial infections. We did a Medline search, for English language articles published until January 2014, using the key words "urticaria" and "bacteria/bacterial disease"; a second analysis was performed in groups of bacteria an…

Pulmonary and Respiratory MedicineUrticariaPATHOGENESISCHILDRENBrucellaLyme diseaseANGIOEDEMAimmune system diseasesHELICOBACTER-PYLORIMYCOPLASMA-PNEUMONIAE INFECTION; HELICOBACTER-PYLORI; LYME-DISEASE; ANGIOEDEMA; CHILDREN; BRUCELLOSIS; VASCULITIS; MANIFESTATIONS; PATHOGENESIS; EOSINOPHILIAparasitic diseasesHumansImmunology and AllergyMedicineVASCULITISskin and connective tissue diseasesBRUCELLOSISBacterial diseaseChlamydiaEOSINOPHILIAAngioedemabiologybusiness.industryLYME-DISEASEBacterial InfectionsGeneral MedicineHelicobacter pylorimedicine.diseasebiology.organism_classificationMANIFESTATIONSMycoplasma pneumoniaImmunologyMYCOPLASMA-PNEUMONIAE INFECTIONmedicine.symptombusinessPneumonia (non-human)
researchProduct

Incidence and Clinical Impact of Right Ventricular Involvement (Biventricular Ballooning) in Takotsubo Syndrome

2021

Background The short- and long-term prognosis of Takotsubo syndrome (TTS) presenting with right ventricular (RV) involvement remains poorly understood. Research Question What is the incidence and clinical outcome of RV involvement in TTS? Study Design and Methods This study analyzed 839 consecutive patients with TTS (758 female subjects and 81 male subjects) in a multicenter registry. RV involvement was defined as wall motion abnormality of the RV free wall, with or without apical involvement. The median long-term follow-up was 2.1 years (interquartile range, 0.3-4.5 years). The primary outcome was in-hospital and out-of-hospital all-cause mortality. The secondary end point was a composite …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyEjection fractionbusiness.industryCardiogenic shockIncidence (epidemiology)Hazard ratioCritical Care and Intensive Care Medicinemedicine.diseasePulmonary edemaClinical trial03 medical and health sciences0302 clinical medicine030228 respiratory systemInterquartile rangeInternal medicineCohortmedicineCardiology030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessChest
researchProduct

Timing of Renal Replacement Therapy for Severe Acute Kidney Injury in Critically Ill Patients

2019

Acute kidney injury (AKI) affects many ICU patients and is responsible for increased morbidity and mortality. Although lifesaving in many situations, renal replacement therapy (RRT) may be associated with complications, and the appropriate timing of its initiation is still the subject of intense debate. An early initiation strategy can prevent some metabolic complications, whereas a delayed one may allow for renal function recovery in some patients without need for this costly and potentially dangerous technique. For years, most of the knowledge on this issue stemmed from observational studies or small randomized controlled trials. Recent randomized controlled trials have indicated that a w…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyHyperkalemiamedicine.medical_treatmentRenal functionurologic and male genital diseasesCritical Care and Intensive Care Medicinelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawmedicine030212 general & internal medicineRenal replacement therapyIntensive care medicinebusiness.industryAcute kidney injurymedicine.diseasePulmonary edemafemale genital diseases and pregnancy complications030228 respiratory systemObservational studymedicine.symptombusinessWatchful waitingAmerican Journal of Respiratory and Critical Care Medicine
researchProduct

Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry

2021

OBJECTIVE: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension following Phase 3 randomized trials. The EXPosurE Registry RiociguaT in patients with pulmonary hypertension (EXPERT) study was designed to monitor the long-term safety of riociguat in clinical practice. METHODS: EXPERT was an international, multicenter, prospective, uncontrolled, non-interventional cohort study of patients treated with riociguat. Patients were followed for at least 1 year and up to 4 years from enrollment or until 30 days after stopping ri…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyRegistryMedDRAPeripheral edemaClinical practicePulmonary arterial hypertensionRiociguatlaw.inventionPulmonary hypertension03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemedicine030212 general & internal medicineAdverse effectHipertensió pulmonarRiociguatbusiness.industrymedicine.diseasePulmonary hypertensionClinical trial030228 respiratory systemPulmonary hemorrhagemedicine.symptomSafetybusinessmedicine.drug
researchProduct

A new pyrazolo pyrimidine derivative inhibitor of cyclooxygenase-2 with anti-angiogenic activity

2003

In a previous study, we reported a new pyrazolo pyrimidine derivative, N(4)-benzyl-N(6),N(6)-dimethyl-1-1(tert-butyl)-1H-pyrazolo[3,4-d]pyrimidine-6,4-diamine (DPP), which inhibited potently cyclooxygenase-2 activity in intact cell assays with minor activity against cyclooxygenase-1 (IC(50)=0.9 nM for cyclooxygenase-2 versus IC(50)=59.6 nM for cyclooxygenase-1). In the present work, this behaviour was confirmed in vivo by using the 24-h zymosan-injected mouse air pouch model (ID(50)=1.36 nM/pouch for prostaglandin E(2) level). We also studied the possible beneficial effect of DPP in the angiogenesis-dependent murine air pouch granuloma and rat paw carrageenan-induced hyperalgesia models. DP…

Pyrimidinemedicine.medical_treatmentAngiogenesis InhibitorsPharmacologyCarrageenanDinoprostoneMicechemistry.chemical_compoundIn vivomedicineAnimalsEdemaCyclooxygenase InhibitorsRats WistarProstaglandin E2IC50NitrobenzenesPharmacologySulfonamidesGranulomaCyclooxygenase 2 InhibitorsNeovascularization PathologicbiologyTumor Necrosis Factor-alphaZymosanRatsIsoenzymesPyrimidinesEicosanoidchemistryBiochemistryCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesHyperalgesiabiology.proteinPyrazolesFemaleCyclooxygenasemedicine.symptomInterleukin-1Prostaglandin Emedicine.drugEuropean Journal of Pharmacology
researchProduct

Pharmacological approach to the pro- and anti-inflammatory effects of Ranunculus sceleratus L.

2003

Ranunculus sceleratus is a widespread species with unique toxicological and pharmacological activities. The present study seeks to assess this species' ability, both in vitro and in vivo, to modulate processes involved in inflammations. To this end, different extracts from the aerial parts of the plant were tested in several models of acute inflammation induced by tetradecanoylphorbol acetate (TPA), arachidonic acid (AA), and carrageenan, as well as in two models of delayed hypersensitivity induced by oxazolone and dinitrofluorobencene (DNFB). The extracts were also assayed in models of eicosanoid and elastase release by intact cells. When tested in vivo, all of the extracts showed anti-inf…

RanunculusCell SurvivalNeutrophilsmedicine.drug_classAnti-Inflammatory AgentsIn Vitro TechniquesBiologyDermatitis ContactAnti-inflammatoryOxazoloneMicechemistry.chemical_compoundIn vivoDrug DiscoverymedicineAnimalsEdemaRanunculus sceleratusRats WistarPeritoneal CavityInflammationPharmacologyPlant ExtractsPlant Components Aerialbiology.organism_classificationRatsBiochemistrychemistryEicosanoidDelayed hypersensitivityTetradecanoylphorbol AcetateFemalePhytotherapyEicosanoid ProductionJournal of Ethnopharmacology
researchProduct